We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

217 hedge funds and large institutions have $1.1B invested in SANGAMO THERAPEUTICS INC in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 57

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

19% more capital invested

Capital invested by funds: $919M → $1.1B (+$178M)

3% more funds holding

Funds holding: 210 → 217 (+7)

0% more call options, than puts

Call options by funds: $36.1M | Put options by funds: $36M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.09% less ownership

Funds ownership: 63.79% → 63.7% (-0.09%)

Holders
217
Holders Change
+7
Holders Change %
+3.33%
% of All Funds
4.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
74
Reduced
57
Closed
28
Calls
$36.1M
Puts
$36M
Net Calls
+$97K
Net Calls Change
+$2.61M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.5M
2
Goldman Sachs
Goldman Sachs
New York
+$9.13M
3
CC
Casdin Capital
New York
+$9.12M
4
WA
Wasatch Advisors
Utah
+$7.39M
5
Millennium Management
Millennium Management
New York
+$6.81M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$28.1M
2
EC
EcoR1 Capital
California
-$17.7M
3
NC
Nexthera Capital
New York
-$15.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$9.01M +$1.82M +120,025 +29%
Citadel Advisors
27
Citadel Advisors
Florida
$8.7M +$4.53M +297,808 +138%
OM
28
Opaleye Management
Massachusetts
$8.3M -$228K -15,000 -3%
Invesco
29
Invesco
Georgia
$8.29M -$1.25M -82,159 -14%
Millennium Management
30
Millennium Management
New York
$7.88M +$6.81M +447,932 +2,649%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$7.71M +$114K +7,472 +2%
FCM
32
Frontier Capital Management
Massachusetts
$7.65M -$247K -16,225 -3%
Allianz Asset Management
33
Allianz Asset Management
Germany
$6.42M +$1.64M +107,872 +40%
PAMU
34
Pictet Asset Management (UK)
United Kingdom
$5.94M +$774K +50,903 +17%
EC
35
EcoR1 Capital
California
$5.82M -$17.7M -1,166,440 -77%
SAM
36
Stansberry Asset Management
Texas
$5.64M +$1.25M +81,999 +33%
Nordea Investment Management
37
Nordea Investment Management
Sweden
$5.39M +$1.91M +125,903 +66%
AGA
38
Altrinsic Global Advisors
Connecticut
$5.25M +$760K +50,000 +19%
AG
39
Artal Group
Luxembourg
$5.08M +$1.52M +100,000 +50%
Capital Fund Management (CFM)
40
Capital Fund Management (CFM)
France
$4.64M +$4.16M +273,584 New
FLAM
41
First Light Asset Management
Minnesota
$4.51M +$1.68M +110,529 +71%
FCMI
42
Foresite Capital Management III
California
$4.5M – – –
WM
43
WS Management
Florida
$4.12M – – –
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$3.75M +$3.37M +221,537 New
CAM
45
Cormorant Asset Management
Massachusetts
$3.39M -$2.77M -182,192 -48%
PP
46
PDT Partners
New York
$3.33M -$1.5M -98,794 -33%
American Century Companies
47
American Century Companies
Missouri
$3.07M -$1.33M -87,189 -33%
Swiss National Bank
48
Swiss National Bank
Switzerland
$3M +$59.3K +3,900 +2%
TCM
49
Tekla Capital Management
Massachusetts
$2.91M +$781K +51,377 +43%
DC
50
Davenport & Co
Virginia
$2.87M +$1.57M +103,510 +158%
1
2
3 4 5

SGMO Hedge Fund Activity: Q3 2018 in Review

217 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2018, worth a combined $1.1B — up 19% from $919M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 28 closed out — a net gain of 7 holders — while 74 added to existing stakes and 57 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $15.5M. The largest seller was Adage Capital Partners, cutting an estimated $28.1M.

  • 217 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2018, up from 210 in Q2 2018.
  • Funds reported $1.1B of SANGAMO THERAPEUTICS INC stock for Q3 2018, up 19% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2018 and 28 closed out, a net change of +7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2018 was Wellington Management Group, an estimated $15.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2018 was Adage Capital Partners, an estimated $28.1M sold.

Based on aggregated 13F filings for Q3 2018.